KMT2A and acute lymphoblastic leukemia: Collectively, these analyses highlighted a putative role for HOXA9 and MEIS1 in KMT2A-rearranged ALL, GATA3 in ZNF384-rearranged ALL, and RARA in PAX5-altered B-ALL.